AbbVie Strikes Tentative Deal In Testosterone MDL
AbbVie Inc., the last remaining company to face claims that it failed to warn patients about the hidden dangers of testosterone replacement therapy products, has reached a tentative deal to exit...To view the full article, register now.
Already a subscriber? Click here to view full article